Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[The Zika virus out of America].
Trilla A, Vilella A. Trilla A, et al. Among authors: vilella a. Med Clin (Barc). 2016 Apr 1;146(7):308-10. doi: 10.1016/j.medcli.2016.02.004. Epub 2016 Mar 2. Med Clin (Barc). 2016. PMID: 26947169 Spanish. No abstract available.
The COVID-19 Pandemic-an Epidemiological Perspective.
Vilella A, Trilla A. Vilella A, et al. Curr Allergy Asthma Rep. 2021 Apr 28;21(4):29. doi: 10.1007/s11882-021-01007-w. Curr Allergy Asthma Rep. 2021. PMID: 33907920 Free PMC article. Review.
SARS-CoV2 hospital surveillance and control system with contact tracing for patients and health care workers at a large reference hospital in Spain during the first wave: An observational descriptive study.
Llupià A, de la Torre-Pérez L, Granés L, Olivé V, Baron-Miras L, Torà I, Marin C, Grau J, Soriano I, Roel E, García-Diez M, López-Toribio M, Puig J, Guinovart C, Santana G, Fernández-Torres P, García-Basteiro AL, Prat A, Blanco-Rojas BJ, de Arquer M, Barroso S, Tortajada M, Varela P, Vilella A, Trilla A. Llupià A, et al. Among authors: vilella a. Health Sci Rep. 2022 Feb 26;5(2):e513. doi: 10.1002/hsr2.513. eCollection 2022 Mar. Health Sci Rep. 2022. PMID: 35237730 Free PMC article.
[Influenza A (H1N1): A new e-pidemic].
Vilella A, Trilla A. Vilella A, et al. Med Clin (Barc). 2009 May 30;132(20):783-4. doi: 10.1016/S0025-7753(09)00819-7. Med Clin (Barc). 2009. PMID: 19480889 Spanish. No abstract available.
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.
219 results